Rivaroxaban contraindications: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Protected "Rivaroxaban contraindications": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Rivaroxaban#Contraindications]]
{{Rivaroxaban}}
{{CMG}}; {{AE}} {{AZ}}


 
[[Category: Cardiovascular Drugs]]
==Contraindications==
[[Category: Drug]]
XARELTO is contraindicated in patients with:
 
*active pathological bleeding [see [[Rivaroxaban warnings and precautions |Warnings and Precautions]] (5.2)]
 
*severe hypersensitivity reaction to XARELTO (e.g., [[anaphylactic reactions]]) [see [[Rivaroxaban adverse reactions |Adverse Reactions]] (6.2)] <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = XARELTO (RIVAROXABAN) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] |url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]

Latest revision as of 17:05, 20 August 2015